ES2066434T3 - Nuevos analogos de vitamina d. - Google Patents

Nuevos analogos de vitamina d.

Info

Publication number
ES2066434T3
ES2066434T3 ES91907179T ES91907179T ES2066434T3 ES 2066434 T3 ES2066434 T3 ES 2066434T3 ES 91907179 T ES91907179 T ES 91907179T ES 91907179 T ES91907179 T ES 91907179T ES 2066434 T3 ES2066434 T3 ES 2066434T3
Authority
ES
Spain
Prior art keywords
pct
hydrogen
formula
hydrocarbyl
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91907179T
Other languages
English (en)
Inventor
Martin John Calverley
Gunnar Grue-Sorensen
Ernst Torndal Binderup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Application granted granted Critical
Publication of ES2066434T3 publication Critical patent/ES2066434T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCIONSE REFIERE A COMPUESTOS DE LA FORMULA (I) EN LA CUAL X ES HIDROGENO O HIDROXIDO; Y ES OXIGENO O AZUFRE O AZUFRE OXIDADO (S(O) O S(O2); R1 Y R2, QUE PUEDEN SER LO MISMO O DIFERENTE, SIGNIFICAN HIDROGENO O HIDROCARBIL C1-C6; O R1 Y R2 UNIDAS AL ATOMO DE CARBONO (MARCADO CON UN ASTERISCO EN LA FORMULA I) QUE SOPORTA EL GRUPO X, PUEDEN FORMAR UN ANILLO CARBOCICLICO C3-C6; Q ES UN RADICAL DE HIDROCARBILENO C1-C8. R3 ES HIDROGENO O HIDROCARBIL C1-C6. R1, R2 Y / O Q PUEDEN ESTAR OPCIONALMENTE SUBSTITUIDAS CON UNO O MAS ATOMOS DE DEUTERIO O FLUOR. N ES 0 O 1. LOS PRESENTES COMPUESTOS, QUE PUEDEN USARSE TANTO EN EL CAMPO MEDICO COMO VETERINARIO, MUESTRAN EFECTOS ANTIINFLAMATORIOS E INMUNOMODULADORES ASI COMO UNA FUERTE ACTIVIDAD EN LA INHIBICION DE LA PROLIFERACION DE CIERTAS CELULAS NO DESEABLES, INCLUYENDO LAS CELULAS CANCERIGENAS Y CELULAS DE LA PIEL.
ES91907179T 1990-03-30 1991-03-22 Nuevos analogos de vitamina d. Expired - Lifetime ES2066434T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007236A GB9007236D0 (en) 1990-03-30 1990-03-30 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2066434T3 true ES2066434T3 (es) 1995-03-01

Family

ID=10673606

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91907179T Expired - Lifetime ES2066434T3 (es) 1990-03-30 1991-03-22 Nuevos analogos de vitamina d.

Country Status (15)

Country Link
US (1) US5374629A (es)
EP (1) EP0522013B1 (es)
JP (1) JP3246913B2 (es)
KR (1) KR100209179B1 (es)
AT (1) ATE114302T1 (es)
AU (1) AU630804B2 (es)
CA (1) CA2073983C (es)
DE (1) DE69105267T2 (es)
DK (1) DK0522013T3 (es)
ES (1) ES2066434T3 (es)
GB (1) GB9007236D0 (es)
GR (1) GR3015127T3 (es)
IE (1) IE65283B1 (es)
NZ (1) NZ237607A (es)
WO (1) WO1991015475A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4101953A1 (de) * 1991-01-19 1992-07-23 Schering Ag 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel
GB9223061D0 (en) * 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US6407082B1 (en) 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
DK0755922T3 (da) * 1994-04-11 2000-11-13 Chugai Pharmaceutical Co Ltd 22-Thiavitamin D3-derivat
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US6242434B1 (en) 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL118156A (en) * 1995-05-09 2001-08-26 Duphar Int Res Vitamin d compounds, their preparation and pharmaceutical compositions containing them
DE19519273A1 (de) * 1995-05-22 1996-11-28 Schering Ag Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie
AU7364896A (en) * 1995-10-10 1997-04-30 Marilyn Strube Treatment of pruritus with vitamin d and analogs thereof
US5738745A (en) * 1995-11-27 1998-04-14 Kimberly-Clark Worldwide, Inc. Method of improving the photostability of polypropylene compositions
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
US6034074A (en) * 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
KR20050123185A (ko) * 1996-12-20 2005-12-29 쥬가이 세이야쿠 가부시키가이샤 16-엔-비타민 ｄ 유도체
MA26481A1 (fr) * 1997-04-21 2004-12-20 Hoffmann La Roche Derives d'arylsecocholadiene
AU728037B2 (en) 1997-05-22 2001-01-04 Cephalon, Inc. Vitamin D analogues and their neuronal effects
JP2002510304A (ja) * 1997-06-06 2002-04-02 ウイスコンシン アラムナイ リサーチ フオンデーシヨン 移植体拒絶反応を防ぐためのビタミンｄ化合物の使用
WO1999049870A1 (en) 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
ATE344039T1 (de) * 1999-04-01 2006-11-15 Univ Johns Hopkins Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung
CZ20013784A3 (cs) * 1999-04-23 2002-05-15 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemis Analogy vitaminu D a jejich farmaceutické vyuľití
KR20020080396A (ko) * 2000-01-31 2002-10-23 레오 파마 에이/에스 골다공증 및 관련 골 질환 치료시의 비타민 ｄ 유도체의용도 및 신규한 비타민 ｄ3 유도체
AU2001228330A1 (en) * 2000-01-31 2001-08-14 Leo Pharma A/S Vitamin d-derivatives and their use in treating osteoporosis and related bone disorders
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
WO2003018545A1 (en) * 2001-08-22 2003-03-06 Johns Hopkins University 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
ATE543796T1 (de) 2002-06-13 2012-02-15 Univ Johns Hopkins 24-sulfoximine vitamin d3 derivate
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
JP2008540513A (ja) 2005-05-10 2008-11-20 ダーミプソル リミテッド スキンケアのための組成物及び方法
DK1879595T3 (en) * 2005-05-10 2015-01-05 Dermipsor Ltd Preparations and Methods for the Treatment of Hyperproliferative Epidermal Diseases
US9481646B2 (en) 2007-04-18 2016-11-01 The Johns Hopkins University Low calcemic, highly antiproliferative, analogs of calcitriol
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
EA201691980A1 (ru) 2009-01-27 2017-07-31 БЕРГ ЭлЭлСи Способы уменьшения побочных эффектов, связанных с химиотерапией
CN102655869B (zh) 2009-08-14 2016-08-10 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
WO2017209934A1 (en) 2016-05-13 2017-12-07 Case Western Reserve University Autophagy activators for treating or preventing skin injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL67153A (en) * 1981-11-02 1986-12-31 Res Inst Medicine Chem Intermediates in the production of vitamin d analogues and method for their production
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
DE3865544D1 (de) * 1987-06-23 1991-11-21 Yamanouchi Pharma Co Ltd Vitamin d3-derivate.
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US5218109A (en) * 1988-07-05 1993-06-08 Kuraray Co., Ltd. Steroid compounds
JPH0667898B2 (ja) * 1989-02-15 1994-08-31 大同ほくさん株式会社 ２２，２３―セコビタミンｄ若しくはその活性型またはそれらの誘導体の製造方法

Also Published As

Publication number Publication date
GR3015127T3 (en) 1995-05-31
ATE114302T1 (de) 1994-12-15
WO1991015475A1 (en) 1991-10-17
DE69105267D1 (de) 1995-01-05
AU7589291A (en) 1991-10-30
EP0522013B1 (en) 1994-11-23
US5374629A (en) 1994-12-20
GB9007236D0 (en) 1990-05-30
DE69105267T2 (de) 1995-04-27
JP3246913B2 (ja) 2002-01-15
EP0522013A1 (en) 1993-01-13
KR920703527A (ko) 1992-12-18
KR100209179B1 (ko) 1999-07-15
AU630804B2 (en) 1992-11-05
IE910970A1 (en) 1991-10-09
CA2073983C (en) 2002-08-20
CA2073983A1 (en) 1991-10-01
JPH05505613A (ja) 1993-08-19
DK0522013T3 (da) 1995-01-30
NZ237607A (en) 1993-05-26
IE65283B1 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
ES2066434T3 (es) Nuevos analogos de vitamina d.
FI943099A0 (fi) Uudet D-vitamiinianalogit
KR950700876A (ko) 비타민 D 동족체(Vitamin D analogues)
DK0820481T3 (da) Nye organiske siliconeforbindelser med en funktionel carboxylgruppe samt fremgangsmåde til fremstilling deraf
ATE81504T1 (de) 4-mercapto-butyramide-n-mono- oder n,ndisubstituiert durch ein mono- oder polyhydroxyalkyl-radikal und ihre verwendung als reduktionsmittel zur dauernden verformung von haaren.
FI956108A0 (fi) Uudet D-vitamiinianalogit
DE69011872D1 (de) Neue vitamin-d-derivate.
PT906276E (pt) Novos analogos da vitamina d
FI951422A0 (fi) Uudet D-vitamiinianalogit
ES8702892A1 (es) Procedimiento para la obtencion de derivados de la 3-nitrodihidropiridina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 522013

Country of ref document: ES